Stay updated on TERN-201 Safety and Efficacy in NASH Clinical Trial

Sign up to get notified when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TERN-201 Safety and Efficacy in NASH Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:33:55.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with the site header/footer and a Home link, signaling an access-restricted state rather than new or updated study content.
    Difference
    17%
    Check dated 2026-09-21T20:38:41.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6 instead of v3.6.5, indicating a software/template update to the page rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-31T16:46:23.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Explicit sponsor attribution now names Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), replacing the previous shorter form. The page revision has been updated to v3.6.5.
    Difference
    0.4%
    Check dated 2026-08-10T12:10:46.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page revision label has been updated to v3.6.4, indicating a newer version of the page content. The previous revision label v3.6.3 has been removed.
    Difference
    0.1%
    Check dated 2026-07-27T05:46:12.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Terminology for liver disease in the study's conditions has been updated from Fatty Liver Disease to Steatotic Liver Disease, aligning with current nomenclature.
    Difference
    0.1%
    Check dated 2026-07-20T00:29:49.000Z thumbnail image

Stay in the know with updates to TERN-201 Safety and Efficacy in NASH Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.